Also, untreated MS patients had significantly greater numbers of CD4+ GM-CSF+ T cells and CD8+ GM-CSF+ T cells in peripheral blood compared with healthy controls and with IFN-β-treated MS patients (73). This evidence concerns the gene CD8A and myeloid sarcoma.